On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...
(Beyond Pesticides, December 17, 2025) In a 50-plus page opinion, the United States Court of Appeals for the Ninth Circuit ruled in October for the plaintiffs on providing general public access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results